Synthace: Revolutionizing Discovery Biology Teams
Overview
Synthace is a remarkable platform that focuses on providing software and expertise tailored to discovery biology teams. It aims to address the challenges faced by these teams in the drug discovery process, enabling them to work more efficiently and achieve better results.
Core Features
- Dedicated Specialists: Synthace has a team of dedicated specialists who become an integral part of your in-house discovery teams. They bring with them decades of experience, lending their knowledge to your scientists. This allows your scientists to run experiments with the added benefit of expert guidance, ensuring projects are controlled from start to finish.
- Software + Dispenser Integrations: The software offered by Synthace structures the approach of scientists to experimentation. It creates a path to standardized insight, providing reliable outputs for making crucial go/no go decisions every time. This integration simplifies the process and enhances the quality of the results obtained.
- Proof of Concept: With Synthace, you don't have to wait long to see the value. From the very first experiment, results are evident. The team utilizes the existing scientists and dispensers in your lab to bring about change and deliver projects on time.
Basic Usage
To get started with Synthace, the process is quite straightforward. First, they help one team adopt their tried-and-tested methods for designing experiments with numerous variables. They also show the team how to automate these experiments using their software. Once this initial step is successful, they then apply the same approach across all the drug discovery teams in your organization. Over time, this helps your scientists become self-sufficient, leading to faster and more definitive results. In comparison to traditional in-house tools that often tie up resources due to being difficult to use, maintain, and adapt, Synthace offers a more streamlined and effective solution for discovery biology teams, making it a valuable asset in the field of drug discovery.
